Disruption of VISTA plays an important role in regulating immune response

Researchers at the Geisel School of Medicine at Dartmouth have found that the body's immune system response was enhanced when they disrupted VISTA, a protein that prevents the immune system from overreacting. Understanding how checkpoint regulators like VISTA function is important to cancer researchers, who hope to use the immune system to attack tumors. The study, "VISTA deficiency synergizes with a nonredundant immune checkpoint pathway and leads to enhanced immune activation," will be presented on April 7, 2014 at the American Association for Cancer Research Annual Meeting in San Diego, CA.

"Because there are multiple immune suppressive pathways, disrupting a single pathway like VISTA might not have led us to obvious alterations in the ," said Li Wang, PhD, assistant professor of Microbiology and Immunology at Geisel. "Our data showed clear chronic inflammation due to VISTA deficiency, which leads us to conclude that VISTA likely plays an important role in regulating immunity."

Wang and her colleagues hope to build on these findings to define the molecular pathway involved in VISTA-mediated immune regulation.

add to favorites email to friend print save as pdf

Related Stories

Discovery brings cancer immune therapies a step closer

Feb 05, 2014

(Medical Xpress)—The development of new therapies to enhance the body's immune response to cancer is much closer after University of Otago scientists identified a pathway that alters the immune response ...

Recommended for you

New hay fever blood test nothing to sneeze at

Sep 29, 2014

(Medical Xpress)—Brisbane researchers have developed a blood test that can accurately detect one of the commonest causes of hay fever, paving the way for new treatments.

Geisel researchers contribute to study of trained immunity

Sep 26, 2014

A study published in the journal science provides support for a new—and still controversial—understanding of the immune system. the research was conducted by collaborators in the U.S. and Europe, including Robert Cramer ...

User comments